What Are Benign Lung Nodules and Benign Lung Tumors? A nodule is a "spot on the lung," seen on an X-ray or computed tomography (CT) scan. In fact, a nodule shows up on about one in every 500 chest ...
A new study of more than 10,000 non-smoking adults found that solid lung nodules were present in a considerable portion of study participants. Non-smokers are traditionally thought to be at low risk ...
Lung nodules are clusters of cells found during an x-ray or CT scan that appear as more dense or white spots in the lungs. They might surprise you because lung nodules generally do not cause symptoms, ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A greater proportion of men vs. women nonsmokers had a ...
OAK BROOK, Ill. – An artificial intelligence (AI) deep learning tool that estimates the malignancy risk of lung nodules achieved high cancer detection rates while significantly reducing false-positive ...
Dr. Russell Hardie with the Department of Electrical and Computer Engineering has been awarded an National Institutes of Health (NIH) grant to harness artificial intelligence (AI) to revolutionize the ...
SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, today released ...
Affinity Technologies (NASDAQ:BIAF) announced on March 10, 2026, the launch of a large longitudinal clinical study involving 2,000 patients to evaluate the performance of its CyPath® Lung technology ...
Lung cancer symptoms don't show up until late stages. So, it is the number one cancer killer for men and women. And in Louisiana, where nearly 20 percent of people smoke, there’s a higher rate of the ...
OXFORD, England, Feb. 27, 2026 /PRNewswire/ -- Optellum, the leading AI-enabled solution for earlier lung cancer detection, is thrilled to announce that it has received Therapeutic Goods ...
bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, today released three additional case studies -- ...